[go: up one dir, main page]

DE19975042I2 - Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen. - Google Patents

Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen.

Info

Publication number
DE19975042I2
DE19975042I2 DE1999175042 DE19975042C DE19975042I2 DE 19975042 I2 DE19975042 I2 DE 19975042I2 DE 1999175042 DE1999175042 DE 1999175042 DE 19975042 C DE19975042 C DE 19975042C DE 19975042 I2 DE19975042 I2 DE 19975042I2
Authority
DE
Germany
Prior art keywords
pdgf
chain
biologically active
factor
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1999175042
Other languages
English (en)
Inventor
Mark Joseph Murray
James Darrel Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45478613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19975042(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/660,496 external-priority patent/US4769328A/en
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DE19975042I2 publication Critical patent/DE19975042I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
DE1999175042 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen. Active DE19975042I2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/660,496 US4769328A (en) 1984-10-12 1984-10-12 Expression of biologically active PDGF analogs in yeast
US06/705,175 US4801542A (en) 1984-10-12 1985-02-25 Expression of biologically active PDGF analogs in eucaryotic cells
CA000492370A CA1340212C (en) 1984-10-12 1985-10-07 Expression of biologically active platelet derived growth factor analogsin eucaryotic cells
CA 617115 CA1340846E (en) 1984-10-12 1999-06-11 Expression of biologically active platelet derived growth factor analogs in eucaryotic cells

Publications (1)

Publication Number Publication Date
DE19975042I2 true DE19975042I2 (de) 2004-01-29

Family

ID=45478613

Family Applications (4)

Application Number Title Priority Date Filing Date
DE1999175042 Active DE19975042I2 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen.
DE3588218T Expired - Lifetime DE3588218T2 (de) 1984-10-12 1985-10-10 Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
DE3586960T Expired - Lifetime DE3586960T3 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen
DE199191121387T Pending DE487116T1 (de) 1984-10-12 1985-10-10 Von blutplaettchen abstammende biologisch aktive analoga eines wachstumsfaktors in eukaryotischen zellen.

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE3588218T Expired - Lifetime DE3588218T2 (de) 1984-10-12 1985-10-10 Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
DE3586960T Expired - Lifetime DE3586960T3 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen
DE199191121387T Pending DE487116T1 (de) 1984-10-12 1985-10-10 Von blutplaettchen abstammende biologisch aktive analoga eines wachstumsfaktors in eukaryotischen zellen.

Country Status (9)

Country Link
US (1) US4801542A (de)
EP (1) EP0177957B2 (de)
JP (2) JP2837407B2 (de)
AT (2) ATE84312T1 (de)
AU (2) AU4845485A (de)
CA (2) CA1340212C (de)
DE (4) DE19975042I2 (de)
LU (1) LU90408I2 (de)
NL (1) NL990016I2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE131532T1 (de) * 1986-08-13 1995-12-15 Zymogenetics Inc Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US5019559A (en) * 1986-11-14 1991-05-28 President And Fellows Of Harvard College Wound healing using PDGF and IGF-II
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
JPH0198489A (ja) * 1987-04-22 1989-04-17 Chiron Corp 血小板由来成長因子ａ鎖ポリペプチドの組換え生産
US6939849B1 (en) 1987-04-22 2005-09-06 Chiron Corporation Recombinant PDGF A-chain homodimers and methods of use
US5219759A (en) * 1987-04-22 1993-06-15 Chiron Corporation Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
US5759815A (en) * 1988-02-11 1998-06-02 Creative Biomolecules, Inc. Production of platelet derived growth factor (PDGF) an muteins thereof
EP0422125B1 (de) * 1988-06-30 1996-10-23 Cor Therapeutics, Inc. Plättchen blockierende peptide
US5037743A (en) * 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
DE3900770A1 (de) * 1989-01-12 1990-07-26 Juergen Prof Dr Hoppe Verfahren zur herstellung von pdgf-a und pdgf-aa
US6899882B1 (en) 1989-03-24 2005-05-31 The Regents Of The University Of California Endothelial cell growth factor methods of isolation and expression
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5272064A (en) * 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
DK0547064T3 (da) * 1990-07-23 1995-03-20 Zymogenetics Inc Proteaseresistent PDGF og anvendelsesfremgangsmåde
US5886141A (en) * 1990-10-26 1999-03-23 Takeda Chemical Industries, Ltd. Smooth muscle mitogen peptides and DNA coding therefor
GB9101645D0 (en) * 1991-01-25 1991-03-06 British Bio Technology Compounds
EP0555785B1 (de) * 1992-02-10 1996-12-04 Takeda Chemical Industries, Ltd. Mitogen für die glatte Muskulatur und dessen kodierende DNS
EP0871730B1 (de) * 1995-10-11 2004-08-18 Chiron Corporation Kombination pdgf, kgf, igf und igfbp zur wundheilung
ATE253120T1 (de) * 1996-12-13 2003-11-15 Chiron Corp Verfahren zur expression von heterologen proteinen in hefe
EP2386629A1 (de) 1997-10-14 2011-11-16 Darwin Molecular Corporation Thymidinkinasemutanten und Fusionsproteine mit Thymidinkinase- und Guanylatkinaseaktivität
US6194169B1 (en) * 1998-06-04 2001-02-27 The University Of Kentucky Research Foundation Enhanced expression of human platelet-derived growth factor in Pichia pastoris
ES2350454T3 (es) 1998-11-27 2011-01-24 Ucb Pharma S.A. Composiciones y métodos para incrementar la mineralización de la sustancia ósea.
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
US7063850B1 (en) 1998-12-22 2006-06-20 University Of Tennessee Research Foundation Protective antigen of group A Streptococci
US6358733B1 (en) * 2000-05-19 2002-03-19 Apolife, Inc. Expression of heterologous multi-domain proteins in yeast
EP1967525B1 (de) 2001-05-08 2012-11-14 Darwin Molecular Corporation Verfahren zur Regulierung der Immunfunktion in Primaten unter Verwendung des foxp3-Proteins
AU2002365223A1 (en) * 2001-10-26 2003-09-02 Id Biomedical Corporation Of Washington Multivalent streptococcal vaccine compositions and methods for use
EP2399586A1 (de) 2002-01-11 2011-12-28 Jefferies, Dr., Wilfred Verwendung von P97 als ein Enzymabgabesystem zur Abgabe therapeutischer lyosomaler Enzyme
US20030139333A1 (en) * 2002-01-18 2003-07-24 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis
US20050048041A1 (en) * 2003-01-13 2005-03-03 Rao Mahendra S. Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
KR20100014290A (ko) * 2006-11-30 2010-02-10 더 유니버시티 오브 브리티쉬 콜럼비아 분자 아주반트로서 ｔａｐ―１ 및/또는 ｔａｐ―２를 포함하는 폭스비리대 치료
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
US9150846B2 (en) 2011-07-05 2015-10-06 Bioasis Technologies, Inc. P97-antibody conjugates and methods of use
EP3321281B1 (de) 2011-08-05 2019-11-27 biOasis Technologies Inc P97-fragmente mit transferaktivität
ES2647082T3 (es) 2012-07-31 2017-12-19 Bioasis Technologies Inc Proteínas desfosforiladas de la enfermedad de depósito lisosómico y métodos de uso de las mismas
WO2014160438A1 (en) 2013-03-13 2014-10-02 Bioasis Technologies Inc. Fragments of p97 and uses thereof
ES2703341T3 (es) 2013-03-14 2019-03-08 Genvivo Inc Ensayo diagnóstico de timidina quinasa para aplicaciones de terapia génica
WO2015117121A1 (en) 2014-02-03 2015-08-06 Bioasis Technologies, Inc. P97 fusion proteins
US10392605B2 (en) 2014-02-19 2019-08-27 Bioasis Technologies Inc. P97-IDS fusion proteins
WO2015168521A2 (en) 2014-05-01 2015-11-05 Bioasis Technologies, Inc. P97-polynucleotide conjugates
EP3206670A4 (de) 2014-10-14 2018-06-20 Samuel Lynch Zusammensetzung zur behandlung von wunden

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350687A (en) * 1980-02-10 1982-09-21 Research Corporation Platelet derived cell growth factor
AU600885B2 (en) * 1984-05-25 1990-08-30 Zymogenetics Inc. Stable DNA constructs

Also Published As

Publication number Publication date
DE487116T1 (de) 1992-10-15
ATE188255T1 (de) 2000-01-15
CA1340212C (en) 1998-12-15
EP0177957B1 (de) 1993-01-07
NL990016I2 (nl) 1999-11-01
JPS62278A (ja) 1987-01-06
EP0177957A3 (en) 1988-02-03
AU638010B2 (en) 1993-06-17
DE3588218D1 (de) 2000-02-03
JPH10117790A (ja) 1998-05-12
DE3586960T3 (de) 2005-01-20
AU5488590A (en) 1991-01-31
DE3586960D1 (de) 1993-02-18
DE3588218T2 (de) 2000-05-18
DE3586960T2 (de) 1993-05-13
NL990016I1 (nl) 1999-08-02
EP0177957B2 (de) 2004-08-25
JP2837407B2 (ja) 1998-12-16
JP3145968B2 (ja) 2001-03-12
CA1340846E (en) 1999-12-07
LU90408I2 (fr) 1999-08-25
US4801542A (en) 1989-01-31
AU4845485A (en) 1986-04-17
ATE84312T1 (de) 1993-01-15
EP0177957A2 (de) 1986-04-16

Similar Documents

Publication Publication Date Title
DE19975042I2 (de) Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen.
KR910015309A (ko) 종양괴사인자(tnf) 억제제 및 그 제조방법
NO174965C (no) Syntetisk polypeptidanalog av humaninsulinlignende vekstfaktor med redusert binding til bærerproteiner i serum, samt syntetiske gener som koder for slike analoger og preparater som omfatter en slik analog
DE69020335D1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
DE3786321D1 (de) Expression von protein-c.
NO179106C (no) Fremgangsmåte for fremstilling av og ekspresjonssystem som koder for og kan uttrykke et rekombinant proteinkompleks med humanfaktor V111:C-aktivitet
ATE50596T1 (de) Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung.
AU7681687A (en) Expression of platelet-derived growth factor and analogues
ATE93272T1 (de) Expression von protein c.
DK92784D0 (da) Dna-struktur til anvendelse ved fremstilling af insulin
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
GR3015689T3 (en) Process for the construction of an animal cell line for the production of human beta-interferon.
ES2078243T3 (es) Mejoras en o relativas a la expresion eucariotica.
DE3650477D1 (de) Produktion von Cystinreste enthaltenden aktiven Proteinen
AU6020086A (en) High level production of bovine growth hormone
PT82860B (pt) Metodo para a producao da hormona de crescimento suina
JPS6437291A (en) Human cytochrome c gene and use thereof
HUP9800520A2 (hu) Génexpresszió emlős sejtekben
SU592399A1 (ru) Стимул тор выгонки лука
JPS6479200A (en) Human placental decidual cell-derived protein
DE58909205D1 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.